AVANTEC

Serial Number 97871034
606

Registration Progress

Application Filed
Apr 3, 2023
Under Examination
Apr 16, 2024
Approved for Publication
Jan 31, 2024
Published for Opposition
Feb 20, 2024
Registered

Attorney Assistance

Abandonment Notice E-Mailed - No Use Statement Filed
Due: Jan 24, 2026 25 days
Revival assistance for abandoned trademark

Trademark Image

AVANTEC

Basic Information

Serial Number
97871034
Filing Date
April 3, 2023
Published for Opposition
February 20, 2024
Abandonment Date
November 24, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Nov 24, 2025
Classes
005 010

Rights Holder

AVANTEC VASCULAR CORPORATION

03
Address
870 HERMOSA DR.
SUNNYVALE, CA 94085

Ownership History

AVANTEC VASCULAR CORPORATION

Original Applicant
03
SUNNYVALE, CA

AVANTEC VASCULAR CORPORATION

Owner at Publication
03
SUNNYVALE, CA

Legal Representation

Attorney
BRIAN S. BOYER, PH.D.

USPTO Deadlines

Next Deadline
25 days remaining
Abandonment Notice E-Mailed - No Use Statement Filed
Due Date
January 24, 2026

Application History

26 events
Date Code Type Description Documents
Nov 24, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Nov 24, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Nov 24, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Nov 24, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Feb 21, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 20, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Dec 11, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 11, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 24, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 22, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 22, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 22, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 16, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 4, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 20, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 1, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 1, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 31, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 16, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 21, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 21, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Dec 21, 2023 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Dec 21, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Dec 12, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 27, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 6, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Cardiovascular pharmaceutical preparations; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for an implantable device that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for an implantable vascular device that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for a stent that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for a vascular stent that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of coatings for use on medical devices that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of vascular disease; Pharmaceutical preparations for the treatment and prevention of restenosis; Pharmaceutical preparations for the treatment and prevention of inflammation; None of the foregoing used for veterinary purposes
Class 010
Medical devices for use in treating vascular disease; Medical devices for use in treating a thrombosis; Medical devices for use in treating cardiovascular disease; Medical devices for use in treating atherosclerosis; Medical devices for use in treating restenosis; Surgical instruments, namely, interventional devices; Surgical instruments, namely, thrombectomy devices; Surgical instruments, namely, vascular surgery devices; Surgical instruments, namely, atherectomy devices; Surgical instruments, namely, vascular retrieval systems; Surgical instruments, namely, vascular guide wires; Surgical instruments, namely, vascular coil devices; Surgical instruments, namely, vascular coil delivery systems; Surgical instruments, namely, drug delivery devices; Surgical instruments, namely, vascular dilation devices; Surgical instruments, namely, vascular stent devices; Surgical instruments, namely, vascular stent delivery systems; Surgical instruments, namely, balloon dilatation devices

Classification

International Classes
005 010